Company Profiles

driven by the PitchBook Platform

American Gene Technologies International

Description

Developer of bio-safe lentivirus therapies designed to treat cancer, metabolic disorders and infectious diseases. The company's lentivirus therapies incorporate a novel, proprietary technology for the clinical application of gene expression technology in cancer therapy, autosomal disorders, stem cell treatment and other applications, enabling patients to begin their treatment more quickly and result in a higher likelihood of a successful treatment.

2007

Founded

PRIVATE

Status

11-50

Employees

Angel

Latest Deal Type

$1.16M

Latest Deal Amount

$2.83M

Total Amount Raised

Description

Developer of bio-safe lentivirus therapies designed to treat cancer, metabolic disorders and infectious diseases. The company's lentivirus therapies incorporate a novel, proprietary technology for the clinical application of gene expression technology in cancer therapy, autosomal disorders, stem cell treatment and other applications, enabling patients to begin their treatment more quickly and result in a higher likelihood of a successful treatment.

Website:

www.americangene.com

Ownership Status

Privately held (backing)

Financing Status

Angel-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals
Biotechnology

Primary Office

15010 Broschart Road Suite 110 Rockville, MD 20850United States +1 (301) 337-2100
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore American Gene Technologies International's full profile, request a free trial.

American Gene Technologies International Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

American Gene Technologies International Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
National Institutes of HealthGovernment000 0000000 0000
National Institutes of Health Government

American Gene Technologies International Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Jeffrey GalvinCo-Founder, Chief Executive Officer and Board Member
John MatthewsChief Strategy Officer
Shannah KossChief Strategy Officer
David PauzaChief Science Officer
Dan Sussman Ph.DVice President of Research & Development
Jeffrey Galvin Co-Founder, Chief Executive Officer and Board Member
John Matthews Chief Strategy Officer
Shannah Koss Chief Strategy Officer
David Pauza Chief Science Officer
Dan Sussman Ph.D Vice President of Research & Development

American Gene Technologies International Board Members (4)

NameRepresentingRoleSinceContact
Info
Aaron GalvinAmerican Gene Technologies InternationalBoard Member000 0000
Qi TangAmerican Gene Technologies InternationalBoard Member000 0000
Stuart BakerAmerican Gene Technologies InternationalBoard Member000 0000
Tommy Thompson JDSelfBoard Member, Director and Senior Advisor000 0000
Aaron Galvin Board Member American Gene Technologies International
Qi Tang Board Member American Gene Technologies International
Stuart Baker Board Member American Gene Technologies International
Tommy Thompson JD Board Member, Director and Senior Advisor Self
Request full access to PitchBook